Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:56 PM
Ignite Modification Date:
2025-12-24 @ 6:56 PM
NCT ID:
NCT04733157
Eligibility Criteria:
Inclusion Criteria: Women undergoing elective or emergency caesarean section with:
* Estimated gestational age of 37 weeks or more
* Live intrauterine foetus
* Elective or emergency caesarean delivery
* Signed informed consent
Exclusion Criteria:
* History of coagulopathies or conditions predisposing them to thromboembolic phenomena,
* seizure history,
* autoimmune disease,
* placental abruption,
* placenta praevia,
* abnormally adherent placentae if identified on prenatal ultrasound,
* eclampsia or HELLP syndrome,
* known hypersensitivity to TXA,
* planned general anaesthesia,
* caesarean delivery for the second twin or second/third triplet(s) after vaginal birth of the first twin,
* poor understanding of English/Shona languages,
* those who have received anticoagulants in the week before delivery
* persons-under-investigation for Coronavirus disease (COVID-19) and confirmed COVID-19 positive women
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT04733157
Study Brief:
Protocol Section:
NCT04733157